"Use of brentuximab vedotin as salvage therapy pre‐allogeneic stem cell transplantation in relapsed/refractory CD30 positive lympho‐proliferative disorders: a single centre experience"

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Use of brentuximab vedotin as salvage therapy pre‐allogeneic stem cell transplantation in relapsed/refractory CD30 positive lympho‐proliferative disorders: a single centre experience

The role of brentuximab peri‐allogeneic transplantation in patients with relapsed and/or refractory CD30 positive lymphomas remains poorly defined. Click to show full abstract

The role of brentuximab peri‐allogeneic transplantation in patients with relapsed and/or refractory CD30 positive lymphomas remains poorly defined.

Keywords: relapsed refractory; transplantation; cd30 positive; brentuximab; refractory cd30

Journal Title: Internal Medicine Journal
Year Published: 2017

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
0

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended